Literature DB >> 8896311

Assessment of the nocturnal blood pressure relative to sleep stages in patients with obstructive sleep apnea.

L Grote1, J Heitmann, U Köhler, T Penzel, J H Peter, P Wichert.   

Abstract

To determine the mean blood pressure relative to sleep stages, two nocturnal cardiorespiratory polysomnographs were recorded in 60 male patients with hypertension and obstructive sleep apnea (OSA). The mean age was 50.2 years, the BMI 32.0 kg/m2, the respiratory disturbance index (RDI) 44, and the blood pressure by the WHO protocol 158/98 mm Hg. A new evaluation program was used to determine the invasively measured mean arterial pressure (mean +/- SEM) and heart rate (mean +/- SEM) during sleep (mean total sleep time 361 +/- 48 min) referred to sleep stages 1 (99.5 +/- 1.5 mm Hg/67.6 +/- 1.1 bpm), 2 (98.7 +/- 1.6 mm Hg/66.6 +/- 1.1 bpm), 3 (97.6 +/- 1.8 mm Hg/67.4 +/- 1.3 bpm), and 4 (97.6 +/- 2.2 mm Hg/66.3 +/- 1.6 bpm) and to REM sleep (103.3 +/- 1.7 mm Hg/68 +/- 1.2 bpm) as 1 s mean values and to compare them with the waking state (98.3 +/- 1.6 mm Hg/83.6 +/- 1.1 bpm). There was no physiological fall in blood pressure in patients with pronounced OSA. Sleep-stage-specific analysis of invasive continuous blood pressure signals is the gold standard. The sleep structure is disturbed less than with other methods.

Entities:  

Mesh:

Year:  1996        PMID: 8896311

Source DB:  PubMed          Journal:  Z Kardiol        ISSN: 0300-5860


  3 in total

1.  Inspiratory Muscle Training Improves Sleep and Mitigates Cardiovascular Dysfunction in Obstructive Sleep Apnea.

Authors:  Jennifer R Vranish; E Fiona Bailey
Journal:  Sleep       Date:  2016-06-01       Impact factor: 5.849

Review 2.  Blood-pressure variability in patients with obstructive sleep apnea: current perspectives.

Authors:  Oreste Marrone; Maria R Bonsignore
Journal:  Nat Sci Sleep       Date:  2018-08-21

3.  Comparison between blood pressure during obstructive respiratory events in REM and NREM sleep using pulse transit time.

Authors:  Aljohara S Almeneessier; Mana Alshahrani; Salih Aleissi; Omeima S Hammad; Awad H Olaish; Ahmed S BaHammam
Journal:  Sci Rep       Date:  2020-02-24       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.